Page last updated: 2024-08-25

bw 12c79 and Hypoxia

bw 12c79 has been researched along with Hypoxia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleehen, NM; Dixon, AK; Falk, SJ; Miles, K; Ramsay, JR; Ward, R1
Beuzard, Y; Chrétien, N; De Paepe, ME; Hoang, T; Jacmain, J; Saadane, N; Sorette, M; Trudel, M1

Trials

1 trial(s) available for bw 12c79 and Hypoxia

ArticleYear
BW12C perturbs normal and tumour tissue oxygenation and blood flow in man.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1994, Volume: 32, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Cohort Studies; Erythrocytes; Gastrointestinal Neoplasms; Hemoglobins; Humans; Hypoxia; Laser-Doppler Flowmetry; Mitomycin; Muscle, Skeletal; Oxygen; Oxygen Consumption; Oxyhemoglobins; Regional Blood Flow; Skin; Tomography, X-Ray Computed

1994

Other Studies

1 other study(ies) available for bw 12c79 and Hypoxia

ArticleYear
Sickle cell disease of transgenic SAD mice.
    Blood, 1994, Nov-01, Volume: 84, Issue:9

    Topics: Anemia, Sickle Cell; Animals; Antisickling Agents; Benzaldehydes; Disease Models, Animal; Erythrocytes, Abnormal; Erythropoiesis; Hypoxia; Longevity; Lung; Mice; Mice, Transgenic; Microcirculation; Spleen

1994